MB and leprosy: A drastic decrease in ApoA-I levels was observed on Mb pre-MDT patients, correlating with the lower capacity of HDL to mediate cholesterol efflux in Mb patients, which seems to be also lowered in plasma of Mb leprosy patients when compared to HC and Pb patients.